Roche Holding Ag Stock Current Valuation

RHHBF Stock  USD 275.03  7.20  2.69%   
Valuation analysis of Roche Holding AG helps investors to measure Roche Holding's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
275.03
Please note that Roche Holding's price fluctuation is very steady at this time. Calculation of the real value of Roche Holding AG is based on 3 months time horizon. Increasing Roche Holding's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Roche Holding AG is useful when determining the fair value of the Roche otc stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Roche Holding. Since Roche Holding is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Roche OTC Stock. However, Roche Holding's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  275.03 Real  230.57 Hype  275.03 Naive  269.3
The real value of Roche OTC Stock, also known as its intrinsic value, is the underlying worth of Roche Holding AG OTC Stock, which is reflected in its stock price. It is based on Roche Holding's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Roche Holding's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Roche Holding's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
227.69
Downside
230.57
Real Value
302.53
Upside
Estimating the potential upside or downside of Roche Holding AG helps investors to forecast how Roche otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Roche Holding more accurately as focusing exclusively on Roche Holding's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
250.97266.39281.81
Details
Hype
Prediction
LowEstimatedHigh
272.15275.03277.91
Details
Naive
Forecast
LowNext ValueHigh
266.43269.30272.18
Details

Roche Holding AG OTC Stock Current Valuation Analysis

Roche Holding's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Roche Holding Current Valuation

    
  287.91 B  
Most of Roche Holding's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Roche Holding AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Roche Holding AG has a Current Valuation of 287.91 B. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The current valuation for all United States stocks is significantly lower than that of the firm.

Roche Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Roche Holding's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Roche Holding could also be used in its relative valuation, which is a method of valuing Roche Holding by comparing valuation metrics of similar companies.
Roche Holding is currently under evaluation in current valuation category among related companies.

Roche Fundamentals

About Roche Holding Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Roche Holding AG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Roche Holding using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Roche Holding AG based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Roche Holding in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Roche Holding's short interest history, or implied volatility extrapolated from Roche Holding options trading.

Currently Active Assets on Macroaxis

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Roche Holding AG. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Note that the Roche Holding AG information on this page should be used as a complementary analysis to other Roche Holding's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Complementary Tools for Roche OTC Stock analysis

When running Roche Holding's price analysis, check to measure Roche Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roche Holding is operating at the current time. Most of Roche Holding's value examination focuses on studying past and present price action to predict the probability of Roche Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roche Holding's price. Additionally, you may evaluate how the addition of Roche Holding to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Stocks Directory
Find actively traded stocks across global markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Please note, there is a significant difference between Roche Holding's value and its price as these two are different measures arrived at by different means. Investors typically determine if Roche Holding is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Roche Holding's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.